Severe myelosuppression causing pancytopenia in a patient with Crohn’s disease: an uncommon complication of azathioprine
Sri Lanka Journal of Medical Sciences · 2024
DOI: 10.4038/sljms1.v1i1.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sri Lanka Journal of Medical Sciences, 2024. Verfasst von SNH Nimesha und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Azathioprine, is widely used to treat many diseases as a steroid sparing drug, including inflammatory bowel disease. Whilst it can commonly result in leucopenia, in rare instances, it can cause severe myelosuppression and pancytopenia. We present a patient with Crohn’s disease, who developed severe myelosuppression resulting in pancytopenia and neutropenic sepsis secondary to azathioprine use.
Zitieren
APA
Nimesha, S., & Jayasena, H. (2024). Severe myelosuppression causing pancytopenia in a patient with Crohn’s disease: an uncommon complication of azathioprine. Sri Lanka Journal of Medical Sciences. https://doi.org/10.4038/sljms1.v1i1.7
Vancouver
Nimesha S, Jayasena H. Severe myelosuppression causing pancytopenia in a patient with Crohn’s disease: an uncommon complication of azathioprine. Sri Lanka Journal of Medical Sciences. 2024. doi:10.4038/sljms1.v1i1.7
BibTeX
@article{Nimesha2024,
author = {Nimesha, SNH and Jayasena, H},
title = {Severe myelosuppression causing pancytopenia in a patient with Crohn’s disease: an uncommon complication of azathioprine},
journal = {Sri Lanka Journal of Medical Sciences},
year = {2024},
doi = {10.4038/sljms1.v1i1.7}
}
EUVIMED